Loose skin does not show evenly across the body
A 2025 study in mice showed that prenatal glyphosate exposure at normal levels reshapes the gut microbiome
Expanding Applications: Clinical trials are actively investigating the use of GLP-1 RAs for a wider range of conditions, including addiction, kidney disease, and neurodegenerative disorders, based on their broad physiological effects
Click [...] To view or add a comment, sign in $NVO has started a Phase 1 trial for its new obesity drug candidate LX9851, developed with Lexicon Pharmaceuticals The drug is oral and works differently from current GLP-1 treatments, targeting fat metabolism and satiety signals The study will assess safety in overweight and obese patients, with results expected in Q1 2027 Lexicon receives a $10M milestone payment and could earn up to $1B plus royalties if successful #stocks #Investing To view or add a comment, sign in 16,852 followers
Zizzari, A
Exilis Ultra: Fat Burning & Skin Tightening Even after significant weight loss, some areas may retain stubborn fat deposits and loose skin
